Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Ranokhon Igamberdieva

30 ta ish

Toshkent davlat tibbiyot universiteti

AkademScholarda batafsil koʻrsatkichlar

  1. P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20200 iqtibos
    ABI

  2. Epidemiological, clinical and morphological aspects of kidney damage in COVID-19

    Batir Daminov, Sherzod Abdullaev, Olimkhon Sharapov +1

    MaqolaOchiq kirishCOVID-19 Clinical Research StudiesJournal of Renal Injury Prevention20210 iqtibos
    ABI

  3. MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*

    Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos
    ABI

  4. POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION

    Ranokhon Igamberdieva, Sherzod Abdullaev, Olimkhon Sharapov

    MaqolaOchiq kirishNeurological Disorders and TreatmentsKidney International Reports20210 iqtibos
    ABI

  5. MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

    Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos
    ABI

  6. MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos
    ABI

  7. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos
    ABI

  8. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos
    ABI

  9. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos
    ABI

  10. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos
    ABI

  11. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos
    ABI

  12. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences20220 iqtibos
    ABI

  13. #3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishDialysis and Renal Disease ManagementNephrology Dialysis Transplantation20230 iqtibos
    ABI

  14. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 iqtibos
    ABI

  15. #2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD

    Sherzod Abdullaev, Olimkhon Sharapov, Ranokhon Igamberdieva

    MaqolaOchiq kirishSARS-CoV-2 and COVID-19 ResearchNephrology Dialysis Transplantation20230 iqtibos
    ABI

  16. #3897 STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE HEART IN ELDERLY AND OLD PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishHealthcare Systems and Public HealthNephrology Dialysis Transplantation20230 iqtibos
    ABI

  17. #1912 Assessment of the dynamics of renal anemia in patients with atrial fibrillation and chronic kidney disease stage IIIb-V during anticoagulant therapy

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishHealthcare Systems and Public HealthNephrology Dialysis Transplantation20240 iqtibos
    ABI

  18. #2562 Effect of rituximab on post-transplant outcome in highly sensitized patients

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation20240 iqtibos
    ABI

  19. #1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos
    ABI

  20. #1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos
    ABI

  21. #377 Assessment of kidney function by creatinine and cystatin C and cardiovascular outcomes in patients with atrial fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishBlood Pressure and Hypertension StudiesNephrology Dialysis Transplantation20240 iqtibos
    ABI

  22. #206 The effect of dapagliflozin on anemia in patients with CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos
    ABI

  23. WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOchiq kirishAmyloidosis: Diagnosis, Treatment, OutcomesKidney International Reports20250 iqtibos
    ABI

  24. #1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation

    Ranokhon Igamberdieva, Sherzod Abdullaev, Музаффар Илхомжон Асомов

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 iqtibos
    ABI

  25. #2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease

    Rakhimjon Tursunbayev, Sherzod Abdullaev, Музаффар Илхомжон Асомов +1

    MaqolaLiver Disease Diagnosis and TreatmentNephrology Dialysis Transplantation20250 iqtibos
    ABI